Dr. Thomas Carr is an associate in the Intellectual Property practice group in the firm's Washington, D.C. office.

Areas of Practice

Dr. Carr is a registered patent attorney and represents domestic and international clients in intellectual property litigation and counseling. Specifically, he specializes in the fields of molecular biology, pharmaceuticals, pharmaceutical small molecules, nutraceuticals, contraceptives, cell and gene therapies, regenerative medicine, immunotherapy, dermatological compositions, bioinformatics, diagnostics, and medical products and devices.

Dr. Carr represents clients in all phases of patent litigation, from pre-suit diligence and the filing of a complaint through appeal. Dr. Carr has significant deposition, court hearing, and trial experience. Dr. Carr’s litigation experience includes district court infringement actions, Federal Circuit appeals, ANDA litigation under the Hatch-Waxman Act, and § 1498 litigation against the United States of America. Dr. Carr also develops patent portfolios for clients. He has significant experience preparing, prosecuting, and obtaining patents for clients, counseling clients on portfolio management, and rendering opinions on infringement, freedom-to-operate, and risks associated with ANDA filings.

While pursuing his Ph.D. at the University of Delaware, Dr. Carr wrote his dissertation on “Expanding the Avian Micro RNA Repertoire of Domesticated Poultry and Investigating the NLRP3 Inflammasome Messenger RNA and Micro RNA Transcriptomes in Anas Platyrhynchos (Ducks).” Dr. Carr focused his research on miRNA characterization, investigating the avian upper respiratory viral microbiome, and developing sequencing pipelines using open source software for DNA, RNA, and miRNA transcriptomes. His technical experience includes biochemistry, bioinformatics, computational biology, genetics, molecular biology, and virology.

Prior to graduate school, Dr. Carr obtained his bachelor’s degree in biochemistry at Widener University. While at Widener, Dr. Carr wrote a senior thesis on “Early Splicing Factors Influence Triglyceride Levels in Drosophila Melanogaster (Fruit Fly).” Dr. Carr’s research involved investigating factors contributing to disease phenotypes and developing quantitative assays.



J.D., Intellectual Property Law Concentration, Antonin Scalia Law School at George Mason University, 2020

Ph.D., Molecular Biology & Genetics, University of Delaware, 2017

B.S., Biochemistry, Widener University, 2010


  • Washington D.C.
  • U.S. Patent and Trademark Office
Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.